LTRN stock

Lantern Pharma Inc (LTRN) financials · $35.1M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Lantern Pharma Inc (LTRN) $35.1M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$18.0M-$22.2M
Net Income-$17.1M-$20.8M
EPS (Diluted)-$1.57-$1.93
Cached annual balance sheet
LineFY2025FY2024
Total Assets$11.0M$25.6M
Current Assets$10.8M$25.2M
Cash & Equivalents$4.42M$7.51M
PP&E$31.9K$47.4K
Total Liabilities$4.50M$4.38M
Current Liabilities$4.50M$4.33M
Shareholders' Equity$6.53M$21.2M
Retained Earnings-$93.1M-$76.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$15.7M-$17.8M
CapEx$1.72K$12.6K
Investing Cash Flow$11.1M$3.37M
Financing Cash Flow$1.50M$66.7K
Net Change in Cash-$3.09M-$14.4M
Free Cash Flow-$15.7M-$17.8M
These statements as JSON? API free 100/day

FAQ

What is LTRN P/E and revenue?

Lantern Pharma Inc (LTRN) $35.1M cap.

What is LTRN revenue?

LTRN income-statement cache has no revenue figure yet.

Is LTRN profitable?

Lantern Pharma Inc last cached net income is -$17.1M (FY2025).

What are LTRN total assets?

Lantern Pharma Inc last cached total assets are $11.0M (FY2025).

What is LTRN free cash flow?

Lantern Pharma Inc last cached free cash flow is -$15.7M (FY2025).

Not investment advice. Cached statements, not a live tape.